PharmaEssentia Corporation Stock LUXEMBOURG S.E.
Stocks
261280523
US7169722037
Biotechnology & Medical Research
|
End-of-day quote
LUXEMBOURG S.E.
19/10/2026
|
5-day change | 1st Jan Change | ||
| 36.20 USD | -5.73% |
|
-3.21% | +167.88% |
| Market Cap | 487B 15B 13.36B 12.38B 11.26B 21.13B 1,423B 21.5B 148B 58.31B 743B 56.27B 55.07B 2,377B | P/E 2026 * |
43.5x | P/E 2027 * | 27.3x |
|---|---|---|---|---|---|
| Enterprise Value | 464B 14.29B 12.73B 11.8B 10.72B 20.13B 1,356B 20.48B 141B 55.55B 708B 53.6B 52.46B 2,264B | EV / Sales 2026 * |
17x | EV / Sales 2027 * | 10.9x |
| Free-Float |
79.23% | Yield 2026 * |
0.34% | Yield 2027 * | 0.2% |
| 1 day | -5.73% | ||
| 1 week | -3.21% | ||
| Current month | -5.24% | ||
| 1 month | -2.16% | ||
| 3 months | -2.16% | ||
| 6 months | +93.18% | ||
| Current year | +167.88% |
| 1 week | 36.2 |  | 38.4 |
| 1 month | 36.2 | | 38.4 |
| Current year | 14.05 | | 49.8 |
| 1 year | 13.06 | | 49.8 |
| 3 years | 8.55 | | 49.8 |
| 5 years | 7.97 | | 49.8 |
| 10 years | 7.97 | | 49.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kuo Chung Lin
CEO | Chief Executive Officer | - | 01/01/2017 |
Hsueh Ling Chang
DFI | Director of Finance/CFO | - | 14/10/2015 |
Cheng Ku Huang
PSD | President | - | 25/06/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
Kuo Chung Lin
BRD | Director/Board Member | - | 09/05/2000 |
Ching-Leou Teng
CHM | Chairman | - | 24/09/2012 |
Cheng Ku Huang
BRD | Director/Board Member | - | 29/05/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.73% | -3.21% | - | - | 15.9B | |
| +1.52% | -7.16% | +51.66% | +67.41% | 65B | |
| +1.52% | +7.17% | +10.77% | +77.89% | 51.2B | |
| +0.30% | +0.19% | +2.53% | +56.14% | 51.19B | |
| -0.38% | +2.31% | +29.98% | +40.71% | 43.93B | |
| +0.30% | +4.43% | +16.99% | +120.94% | 41.96B | |
| +2.35% | -4.01% | +236.69% | +497.21% | 38.14B | |
| +2.16% | +10.36% | +18.92% | +59.70% | 33.24B | |
| -0.90% | -10.49% | +37.09% | +1.80% | 25.2B | |
| +1.60% | +3.97% | +21.34% | +22.33% | 22.5B | |
| Average | +0.27% | +0.14% | +47.33% | +104.90% | 41.37B | |
| Weighted average by Cap. | +0.70% | +0.04% | +46.03% | +106.36% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 27.23B 838M 747M 692M 629M 1.18B 79.58B 1.2B 8.3B 3.26B 41.53B 3.15B 3.08B 133B | 41.51B 1.28B 1.14B 1.06B 960M 1.8B 121B 1.83B 12.66B 4.97B 63.32B 4.8B 4.69B 203B |
| Net income | 10.93B 336M 300M 278M 253M 474M 31.94B 482M 3.33B 1.31B 16.67B 1.26B 1.24B 53.33B | 18.25B 562M 501M 464M 422M 792M 53.34B 806M 5.56B 2.19B 27.84B 2.11B 2.06B 89.08B |
| Net Debt | -23.05B -710M -632M -586M -533M -1B -67.37B -1.02B -7.03B -2.76B -35.16B -2.66B -2.61B -112B | -34.24B -1.05B -939M -871M -792M -1.49B -100B -1.51B -10.44B -4.1B -52.23B -3.96B -3.87B -167B |
| Date | Price | Change |
|---|---|---|
| 19/10/26 | $36.20 | -5.73% |
| 16/10/26 | $38.40 | +3.23% |
| 15/10/26 | $37.20 | +0.54% |
| 14/10/26 | $37.00 | +2.21% |
| 13/10/26 | $36.20 | -2.69% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 6446 Stock
- 261280523 Stock
Select your edition
All financial news and data tailored to specific country editions
